HighTower Advisors
ADMA icon

HighTower Advisors’s ADMA Biologics ADMA Stock Holding History

HighTower Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Sell
16,222
-9,493
-37% -$150K ﹤0.01% 3567
2025
Q4 		$469K Buy
25,715
+1,618
+7% +$27.3K ﹤0.01% 2684
2025
Q3 		$353K Sell
24,097
-11,059
-31% -$190K ﹤0.01% 2900
2025
Q2 		$640K Buy
35,156
+4,948
+16% +$101K ﹤0.01% 2320
2025
Q1 		$599K Sell
30,208
-69,173
-70% -$1.2M ﹤0.01% 2316
2024
Q4 		$1.7M Buy
99,381
+11,910
+14% +$224K ﹤0.01% 1616
2024
Q3 		$1.75M Buy
87,471
+25,492
+41% +$396K ﹤0.01% 1601
2024
Q2 		$692K Sell
61,979
-11,010
-15% -$92.4K ﹤0.01% 2089
2024
Q1 		$482K Buy
72,989
+1,569
+2% +$8.58K ﹤0.01% 2306
2023
Q4 		$326K Sell
71,420
-1,097
-2% -$4.06K ﹤0.01% 2641
2023
Q3 		$258K Buy
72,517
+38,160
+111% +$147K ﹤0.01% 2715
2023
Q2 		$126K Sell
34,357
-300
-0.9% -$1.11K ﹤0.01% 3022
2023
Q1 		$114K Buy
34,657
+12,434
+56% +$43K ﹤0.01% 2911
2022
Q4 		$86K Buy
22,223
+600
+3% +$1.85K ﹤0.01% 2955
2022
Q3 		$53K Buy
+21,623
New +$51.9K ﹤0.01% 2872
2021
Q2 		– Sell
-12,360
Closed -$22K – 3138
2021
Q1 		$22K Buy
+12,360
New +$28.3K ﹤0.01% 2892

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

HighTower Advisors's ADMA Position: Q1 2026 in Review

HighTower Advisors reduced its ADMA Biologics (ADMA) stake by 37% in Q1 2026, selling an estimated $150K and leaving 16,222 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #3567.

HighTower Advisors first reported a position in ADMA in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.75M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • HighTower Advisors held 16,222 shares of ADMA Biologics worth $146K as of Q1 2026.
  • HighTower Advisors sold 9,493 ADMA Biologics shares in Q1 2026, an estimated $150K.
  • ADMA Biologics made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3567 holding.
  • HighTower Advisors first reported a position in ADMA Biologics in Q1 2021 and has held it in 16 quarters since.
  • HighTower Advisors's ADMA Biologics position peaked at $1.75M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.